The first time I tried to remove my personal information from people search sites, it was back online after a few weeks. If the same thing happened to you, you might have decided it's just not worth ...

“We can agree, this mural behind us does not reflect Providence’s values.” Can you guess what kind of mural doesn’t reflect the so-called values of Providence, Rhode Island, according to a local ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Getting your Trinity Audio player ready... Colorado’s wave of craft beer consolidation continued Wednesday as Left Hand Brewing announced that fellow Longmont company Bootstrap Brewing would join its ...

February 17 - Recently acquired Utah Jazz forward Jaren Jackson Jr. had successful surgery on Tuesday to remove a growth in his left knee, the team announced. The Jazz said Jackson, 26, will begin ...

Utah's new big man will be re-evaluated in 4 weeks to determine his recovery status. The Associated Press Jaren Jackson Jr. was acquired by Utah in a trade with Memphis before the trade deadline. SALT ...

SALT LAKE CITY — Utah Jazz forward Jaren Jackson Jr. underwent surgery on Tuesday to remove a growth in his left knee. The Jazz said Jackson will begin rehabilitation and be re-evaluated in four weeks ...

Dealing with hard water stains in your toilet? These left behind mineral deposits can make your toilet look incredibly dark and dingy and be even harder to get rid of the longer they sit. If you live ...

Editor's take: Microsoft is doubling down on its plan to turn Windows 11 into an "agentic AI" platform, and in the process seems determined to strip away the last bits of user agency left in the OS.

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...